Menu Search

Target Healthcare REIT plc

THRL:LSE

Target Healthcare REIT plc

Actions
  • Price (GBX)81.00
  • Today's Change-1.30 / -1.58%
  • Shares traded627.58k
  • 1 Year change-29.44%
  • Beta0.4595
Data delayed at least 20 minutes, as of Jan 31 2023 17:02 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Target Healthcare REIT plc grew revenues 27.77% from 49.98m to 63.86m while net income improved 11.88% from 43.88m to 49.10m.
Gross margin58.24%
Net profit margin76.88%
Operating margin87.23%
Return on assets5.84%
Return on equity7.77%
Return on investment6.00%
More ▼

Cash flow in GBPView more

In 2022, Target Healthcare REIT plc increased its cash reserves by 63.38%, or 13.38m. Cash Flow from Financing totalled 185.62m or 290.67% of revenues. In addition the company generated 30.39m in cash from operations while cash used for investing totalled 202.63m.
Cash flow per share--
Price/Cash flow per share--
Book value per share1.13
Tangible book value per share1.13
More ▼

Balance sheet in GBPView more

Target Healthcare REIT plc has a Debt to Total Capital ratio of 24.88%, a higher figure than the previous year's 22.63%.
Current ratio1.52
Quick ratio--
Total debt/total equity0.3311
Total debt/total capital0.2488
More ▼

Growth rates in GBP

Year on year, growth in dividends per share increased 1.20% while earnings per share excluding extraordinary items fell by -11.22%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)0.05%
Div growth rate (5 year)4.92%
Payout ratio (TTM)85.40%
EPS growth(5 years)1.65
EPS (TTM) vs
TTM 1 year ago		-11.04
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.